Apr 20, 2023 · 1h 42m · my-first-million
Martin Shkreli Reveals How He Made His First $100 Million (#445)
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this wide-ranging interview on My First Million, Martin Shkreli reflects on his journey from teenage hedge fund analyst to controversial biotech founder, addressing the Daraprim pricing backlash, his post-prison legal battles, and the launch of his new AI physician startup, DrGupta.ai.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 23.2% of the talking time here. How this is scored →
The hosts as informed peer 3.2 Guest teaching 4.4 Guest disagreement 4.0 The hosts pushing back 2.1
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 36:15 Shkreli defends pricing sovereignty against public shaming
Shkreli forcefully rejects the premise that public outrage or politicians have any legitimate authority over corporate product pricing, framing regulation by embarrassment as an infringement on business rights.
Hardest push from the hosts ▶ 44:20 Sam Parr calls out Shkreli's self-defeating congressional arroganceSam refuses Shkreli's logical rationalizations, bluntly stating that Shkreli acted foolishly by smirking before Congress and throwing away seven years of freedom over an inability to manage his public image.
Biggest teaching moment ▶ 42:30 Shkreli dismantles generic pricing critiques of orphan drugsShkreli systematically educates the hosts on pharmaceutical reimbursement economics, pointing out that critics who attack per-pill list prices misunderstand out-of-pocket costs, course lengths, and insurer alternative care offsets.
The host holds their own ▶ 1:13:24 Shaan frames the regulatory death trap for AI medical diagnosticsShaan directly counters Shkreli's optimistic product pitch by drawing a precise analogy to autonomous vehicles, highlighting how a single fatal diagnostic edge case creates catastrophic legal and public relations failure modes.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Hook: Mining PubMed to Build Billion-Dollar Companies | 1 | 1 | 1 | 0 | Introductory monologue and teaser by Shaan Puri previewing the wide-ranging conversation with Martin Shkreli. | |
| Early Career, Jim Cramer, and Breaking the Fourth Wall | 2 | 3 | 3 | 1 | Shaan and Sam ask Shkreli about his teenage internship with Jim Cramer and his history of defying authority. Shkreli explains his habit of breaking the fourth wall in business and media meetings. | |
| Hedge Fund Realities and Investor Psychology | 3 | 6 | 3 | 2 | Sam asks why Shkreli failed to profit from hedge funds despite his trading acumen. Shkreli details the psychological traps of portfolio management, regulatory hazards, and the friction of doubling down on bad trades. | |
| The Retrophin Story and Finding Sparsentan on PubMed | 2 | 7 | 3 | 1 | Shkreli recounts founding Retrophin by licensing a discarded Bristol Myers Squibb asset and mining PubMed literature for rare kidney disease applications. | |
| Boardroom Battles, Paper Wealth, and Founding Turing | 3 | 5 | 5 | 1 | Shkreli discusses the paradox of paper wealth versus cash illiquidity after Retrophin's IPO, followed by his boardroom ouster and DOJ investigation. | |
| The Daraprim Controversy and Healthcare Pricing Economics | 4 | 7 | 7 | 6 | The hosts challenge Shkreli on the Daraprim repricing controversy and his combative public persona. Shkreli strongly defends his economic rationale using utility pricing theory and argues that zero percent of patients were denied access. | |
| Sponsor Message: HubSpot CRM | 3 | 4 | 4 | 2 | After an ad break, Sam asks about Shkreli's remaining capital after prison and his ongoing $60M FTC litigation, while Shkreli insists entrepreneurial ability transcends net worth resets. | |
| The Anti-Corporate Movement and Stanford's Fun Strikes Back | 5 | 2 | 4 | 1 | Shaan presents an extended case study on Stanford's 'Fun Strikes Back' student election movement as a parallel to Shkreli's disdain for sanitize-everything corporate culture. | |
| Writing in Prison and Radical AGI Forecasts | 3 | 5 | 3 | 1 | Sam praises Shkreli's newsletter writing, prompting Shkreli to outline his thoughts on prison productivity, John Carmack's Keen Technologies, and aggressive AGI timelines. | |
| Unveiling DrGupta.ai: The AI Physician Platform | 5 | 6 | 7 | 6 | Shkreli announces DrGupta.ai, attacks Mark Cuban's Cost Plus Drugs as deceptive, and faces pushback from Shaan regarding the severe liability hurdles of automated medical diagnosis. | |
| Software Ventures, Streaming Legacy, and Engineering Talent | 5 | 4 | 3 | 1 | Shaan breaks down the three elements that made Shkreli's early finance live-streams viral hits, while Shkreli explains how that content helped him recruit top engineers. | |
| The Origin of the Pharma Bro Photo and Media Villainy | 4 | 4 | 5 | 5 | Sam explains how The Hustle used Shkreli's Flo Rida parody photo to crystallize the 'Pharma Bro' narrative, pressing him on whether his persona ruined his life. | |
| Admiration for Heels: From Vince McMahon to Bill Gates | 3 | 4 | 4 | 1 | Shkreli discusses why he respects unrepentant figures like Vince McMahon and 1990s-era Bill Gates, before the hosts joke about Gates's famous chair-jumping clip. | |
| Platform Censorship, Twitter Bans, and Interview Conclusion | 2 | 3 | 4 | 1 | The conversation concludes with Shkreli discussing his bans across major social platforms and arguing against tech censorship. |
Statements from this episode (30)
Shkreli: Hedge fund industry totaled only $50B to $100B in early 2000s
“Hedge funds were a different world back then. It was a very, very small asset class, maybe fifty billion, a hundred billion totals.”
Shkreli: Great investing and hedge fund management require fundamentally different skills
“Being a good investor and being a good fund manager, kind of like pretty different things is what I think most hedge fund entrepreneurs kind of learn, you know you know, there, you can be a really brilliant investor and not manage the actual business well. And…”
Shkreli: Made first $25 million in a single day
“So when people ask me like, where'd you make your first million? I made my first like, twenty-five million, all one. You still on the same day.”
Shkreli: Five of the top ten hedge funds of all time faced regulatory shutdown
“If you look at the top hedge funds from the nineties, almost none of them exist today. And I think of those like top 10 hedge funds of all time, like five were shut down by regulatory. Intervention.”
Shkreli: Biotech investing teaches operations far better than tech investing
“In biotech, you can actually like learn to pick up most of the operating stuff from being an investor. Whereas I think in tech, like, you know, being an investor in a software company certainly doesn't make you a programmer.”
Shkreli: Vivek Ramaswamy was his biggest investor and supersized his business model
“And my friend and at the time it was actually my biggest investor, Vivek Ramaswamy, he's now running for president. He basically took our business model and supersized it.”
Shkreli: Sifting through PubMed can make anyone a biotech billionaire
“PubMed is the government database of all scholastic biomedical literature. So, thirty-six million papers. If you sit there long enough and you have the passion, you can become a billionaire. It's just a matter of sitting there and sifting and sifting and sifti…”
Shkreli: Made his wealth in clinical drug development, not price hikes
“A lot of people think that I take medicines and raise prices. Well, this drug was barely in human beings. It had been in like 30 or 50 people. Helped up until that point. And, you know, I made most of my money in, in sort of developments in, in environment on …”
Shkreli: Big Law Firms Easily Secure Rapid Federal Indictments
“And it's not hard if you go to a law firm, you know, like a Cooley, Cleary, Gottlieb, Skadden, Arbs, pick your, Paul Weiss, pick your biggest law firm. You say, hey, we have this guy, he did something bad, you know, look into this. You know, usually you'll get…”
Shkreli: Acquitted of Retrophin-Related Federal Criminal Charges
“And it's like, you know, I was actually acquitted of those charges, and I'm so proud of that.”
Shkreli: Drug prices should equal the averted cost of alternative care
“When you do the pricing, I think that the best logical thing to do is pick a price that the alternative care, in other words, a world without this drug, you would forego all those costs for this drug.”
Shkreli: Vertex drug eliminates cystic fibrosis for 90% of patients
“There's this miracle drug by Virtex, one of my favorite drug companies for cystic fibrosis. Miracle product, literally cure for cystic fibrosis. Amazing. Cystic is no longer a medical problem for 90% of people with cystic fibrosis.”
Shkreli: Every insurer covered Daraprim because it was cheaper than ICU stays
“There's not an insurer in the world that didn't cover Daraprim because If you don't pay the 50,000 dollars roughly what Daraprim costs for a whole course, forget per pill, about 50 grand if you end up needing Daraprim. If you don't pay that, you're gonna pay f…”
Shkreli: US healthcare spending will reach 50% of GDP over time
“And that's why we've spent, we've gone from something, five percent of our GDP on healthcare to 20%. And I think that's going to go to 50% over time because our basic goods and needs are Maslowian kind of needs or med, you know, we can eat, we can have shelter…”
Shkreli: Turned a profit selling Wu-Tang album during the NFT boom
“I decided to sell the Wu Tang album which is a funny thing because there's this NFT bubble and I basically said, oh, like if I turn this into an NFT or sell it to a crypto bro, like, you know, I'll, I might even get my money back on this thing because it was b…”
Shkreli: First individual personally sued for monopoly by the FTC
“The Federal Trade Commission actually personally sued me for monopoly. I'm the first person in American history, the Sherman Act, which is 125 years old, the first person to personally be sued by the Federal Trade Commission, which is very odd. Because John D.…”
Shkreli: Predicts the FTC's $60M antitrust ruling against him will be overturned
“And they won. So I'm appealing that, but they won a sixty million dollar hit against me. So until I figure that out, I'm sort of not, not in the market. It's very like bizarre ruling that I think will get overturned.”
Shkreli: Inhibiting one's personality for corporate PR is an insane metagame
“It's an insane meta where you're constantly just like getting to the next point of like inhibiting your personality and what are you really saying? And just come on and say it, you know, and I think that that's a really freeing, you know, thing to do.”
Shkreli: In the future, humans will marry AI and AI will vote
“You know, probably some of the craziest ones I've made, including include things like they'll, they'll be kind of interspecies marriage between AI and humans. There'll be AI fundamental rights for voting and things like that. That'll kind of reshape society. S…”
Shkreli: Google and Meta had OpenAI-equivalent tech years ago but missed productization
“Both Facebook and Google had sort of equivalent technology to open AI, in my opinion, years ago, and they just still just haven't sort of seen the actual product, you know, making sense and launching.”
Shkreli: 90% of healthcare costs stem from physicians and 10% from pharma
“90% of healthcare costs come from physicians. 10% come from pharma.”
Shkreli: Mark Cuban's drug company will not save anyone money
“The, whatever Cuban's doing is not gonna save anybody any money. And it's like, I can make Mark any money either, but this could actually change the curve on healthcare.”
Shkreli: Top software unicorn CEOs and billionaires backed his startup
“And like, I'm so lucky that these people, some of whom started some of the biggest software companies in our industry literally like maybe the top five unicorns in software, like three of the four CEOs. It was like that where, where like I messaged these guys,…”
Shkreli: Machines will replace human doctors entirely within 30 years
“There's, if we do our jobs right, there's no such thing as a doctor in 30 years. That every operation, every prescription, every piece of medical advice you ever get from now on comes from a machine and it costs 10 cents.”
Shkreli: Made $20M shorting Vital Therapies in personal account
“It was in my personal account. We made twenty million dollars shorting the stock called Vital Therapies.”
Shkreli: Deliberately embraced being a villain after intense media backlash
“I realized like, there's no way out of this and I'm gonna have to embrace being the bad guy. And some people will get the joke and some people won't. But you know, fuck it. If that's what people want, then I'll be the bad guy. And I sort of embraced kind of be…”
Shkreli: Bill Gates remains privately ruthless despite philanthropic image
“It's just sort of this public image of like, no, no, I'm this benevolent philanthropist. You don't understand. You know, privately, the guy's still just as ruthless, still just as vicious and just as energetic and intense as he was when he was a kid.”